10

CVE-2006-5374: oracle pharmaceutical

CVSS: 10.0v2.0HighModified
Published 18-10-2006Last modified 07-08-2024
Open JSON

Vulnerability summary

CVE-2006-5374 is a high (CVSS 10.0) vulnerability in oracle pharmaceutical. EPSS estimates a 4.16% chance of exploitation in the next 30 days, higher than 90.8% of scored vulnerabilities.

Overall risk
70/100
0100
High · default modelHow is this calculated?
CVSS score
10.0/10
010
High · v2.0 (NVD)
EPSS score
4.16%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits0No public exploits recorded

Timeline

  1. 18-10-2006
    PublishedVulnerability first disclosed.
  2. 07-08-2024
    Last modifiedVulnerability information updated.

Description

Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.

CVSS metrics

1 score · 1 source · 1 version

EPSS trend

Probability

4.16%

Chance of exploitation in the next 30 days

Percentile

91%

Versus all other CVEs

30-day change

0.00 pp

From 4.16% on 21-09-2026

21-09-202621-10-2026
EPSS score
4.16%

Known exploited

Compare KEV catalogs

Not in any of the 3 tracked catalogs.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

No weakness data has been published for this record.

Affected systems

Oracle1 product

1 vendor · 1 product

References

8 links